Volume 17 - Issue 9 - September 2004

Technology In Practice »

Why Patients May Prefer Arthrodesis With A New Screw

By Brian McCurdy, Associate Editor | 3580 reads | 0 comments

Although performing digital arthrodesis on the lesser metatarsals with the traditional K-wire is reliable, patients may not be pleased with the prospect of a pin sticking out of their feet for several weeks after the procedure. A new screw offers compression, stability and perhaps an improved likelihood of patients enjoying the convenience of internal fixation.
The Digital Compression Screw offers patients an alternative which they may find more cosmetically acceptable. William Hineser, DPM, has been using the screw for several months and says it is easy to install and has a sh

New Products »

Restore Your Patients' Nails

5106 reads | 0 comments

With so many people dealing with dry skin and nail diseases, one cannot have too many options for treatment.
That is why you may want to consider adding two new products to your armamentarium. Keralac® Lotion is a 35% urea-based moisturizer manufactured by Doak Dermatologics. Offering ingredients of vitamin E, lactic acid and zinc, Keralac Lotion can promote a favorable pH level, which can increase healing and protect against harmful bacteria, according to the company.

Available in 7-ounce and 11-ounce bottles, Keralac Lotion has a light texture and patients can spread it eas

Surgical Pearls »

Current Options In Treating Chronic Venous Ulcers

By Michael Baker, DPM, CWS | 8505 reads | 0 comments

As foot and ankle surgeons, we are constantly reminded that we are the ultimate champions of diabetic foot care. However, another emerging problem is chronic venous insufficiency (CVI) ulcerations. While it does not have nearly the potential impact of limb loss one may see with complications from the diabetic foot, there is an increasing incidence of CVI with the continued aging of the population.
According to current estimates, CVI affects between 0.1 and 0.3 percent of the total population in the United States. The healthcare industry spends $400 million annually on treating CVI. Unlike th

News and Trends »

Research Is At The Forefront At Scholl College

By Brian McCurdy, Associate Editor | 4389 reads | 0 comments

Podiatrists like David G. Armstrong, DPM, know the value of research in podiatric medical schools. A Professor of Surgery, Assistant Dean and Chair for Research at Dr. William M. Scholl College of Podiatric Medicine at Rosalind Franklin University of Medicine and Science, Dr. Armstrong says research is part of a “triad of care” along with teaching and patient care.

To that end, the podiatric medical program of Scholl College is looking toward the future with its establishment of a new research focus. Dean Terence Albright, DPM, says the school’s merger with the Rosalind Franklin Univ

Wound Care Q&A »

Key Insights On Managing Infected Diabetic Ulcers

Clinical Editor: Lawrence Karlock, DPM | 12575 reads | 0 comments

Assessing and treating infected diabetic foot wounds can be challenging. Providing timely treatment is essential given the potential complications of diabetic foot infections but the rise in antibiotic resistance is a key issue to consider. With this in mind, our expert panelists discuss a variety of issues, ranging from empiric antibiotic selection and MRSA infected wounds to their approach in diagnosing osteomyelitis.

Q: What empiric antibiotics do you utilize for the infected neuropathic diabetic foot ulcer?
Systemic antibiotics are unnecessary unless there is evidence of os

Feature »

A Closer Look At Nuclear Medical Imaging

By Molly S. Judge, DPM, CNMT, and Nellie L. Kelty, MAS, CNMT | 13753 reads | 0 comments

When a patient with Charcot neuroarthropathy presents with an acutely symptomatic limb, joint or a non-healing wound, the differential diagnosis always includes infection. Bone and joint infections are naturally associated with a high degree of potential morbidity. This potential morbidity is significantly increased when there is a delay in diagnosis or when the diagnosis is missed altogether. Therefore, validating a definitive diagnosis of infection and clarifying when it involves bone is essential to providing appropriate and timely treatment.
Nuclear medicine leukocyte imaging (NMLI) allow